Alamar Biosciences, Inc. Common Stock (ALMR) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · United States · ISIN US0109111056

Price
28.94 USD
Market cap
1.93 bn USD
P/E (2025)
–
P/S (2025)
25.94
Dividend yield
0.00 %
Net margin
-40.18 %
Return on equity (ROE)
18.76 %
Return on assets (ROA)
-21.30 %

Alamar Biosciences, Inc. Common Stock financials

Fiscal year20242025
Revenue25.14 m USD74.21 m USD
Gross profit8.61 m USD41.71 m USD
Operating income-49.57 m USD-31.33 m USD
EBIT-44.98 m USD-28.75 m USD
Net income-47.07 m USD-29.82 m USD
Diluted EPS – continuing operations-0.71 USD-0.45 USD

Full history since 2024, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Alamar Biosciences, Inc. Common Stock

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.